Skip to main content
. 2022 Jun 27;11(13):3713. doi: 10.3390/jcm11133713

Figure 2.

Figure 2

Model for the prediction of the risk of COVID-19 progression in the presence of increased CD8+ T-cell NKG2A MFI and clinical variables. HLA-DR, human leukocyte antigen DR isotope; mAb, monoclonal antibody; MFI, mean fluorescent intensity; NKG2A, natural killer group 2-member A.